Need Help?

Whole genome sequencing data of paediatric T cell acute lymphoblastic leukemia (T-ALL)

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy accounting for approximately 15–25% of pediatric and adult ALL cases. Despite significant therapeutic improvements over the last decade, the prognosis of T-ALL remains less favorable than that of B-ALL, with 5-year EFS and OS of around 76–82% and 80–88%, respectively, depending on the treatment protocol used. T-ALL patients often suffer from failure of induction therapy or early relapse, which is associated with a dismal prognosis. Approximately 10–15% of T-ALL patients experience relapse, and survival after relapse is poor.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000002013 Illumina HiSeq X 2
EGAD50000002014 Illumina HiSeq X Illumina NovaSeq 6000 5
EGAD50000002015 Illumina NovaSeq 6000 Illumina NovaSeq X Plus 5